ReviewFrontiers in pharmacology2022

Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review.

Pía Loren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.